Endocrine-Related Cancer

Submit your manuscript Author guidelines Journal scope Open access Publication charges Review for Endocrine-Related Cancer

Endocrine-Related Cancer key journal metrics

Latest Impact Factor: 5.900

5-year Impact Factor: 5.974

Average time to first response: 13 days

EDITOR-IN-CHIEF

Matthew Ringel MD, PhD
Ralph W. Kurtz Professor of Medicine,
and Director of the Division of Endocrinology and Metabolism
The Ohio State University,
OH, USA

DEPUTY EDITOR

Márta Korbonits MD, PhD
Professor of Endocrinology and Metabolism,
William Harvey Research Institute,
Barts and the London School of Medicine,
Queen Mary University of London, UK

Androgen receptor mutations for precision medicine in prostate cancer

Authors: Masaki Shiota, Shusuke Akamatsu, Shigehiro Tsukahara, Shohei Nagakawa, Takashi Matsumoto, and Masatoshi Eto

Volume 29: Issue 10,
Pages:: R143–R155

miR-3156-5p is downregulated in serum of MEN1 patients and regulates expression of MORF4L2

Authors: Kreepa G Kooblall, Victoria J Stokes, Omair A Shariq, Katherine A English, Mark Stevenson, John Broxholme, Benjamin Wright, Helen E Lockstone, David Buck, Simona Grozinsky-Glasberg, Christopher J Yates, Rajesh V Thakker, and Kate E Lines

Volume 29: Issue 10,
Pages:: 557–568 (12 total)

Second-line treatment and prognostic factors in neuroendocrine carcinoma: the RBNEC study

Authors: Julien Hadoux, Thomas Walter, Christina Kanaan, Ségolène Hescot, Vincent Hautefeuille, Marine Perrier, Igor Tauveron, Sandrine Laboureau, Christine Do Cao, Caroline Petorin, Odile Blanchet, Matthieu Faron, Emmanuelle Leteurtre, Marie-Christine Rousselet, Juliette Joubert Zakeyh, Aude Marchal, Denis Chatelain, Clément Beaulaton, Valérie Hervieu, Catherine Lombard-Bohas, Michel Ducreux, Jean-Yves Scoazec, Eric Baudin, the Groupe d’Etude des Tumeurs Endocrines (GTE), and the ENDOCAN-RENATEN network

Volume 29: Issue 10,
Pages:: 569–580 (12 total)

Clinicopathologic features of thyroid nodules with PTEN mutations on preoperative testing

Authors: Jacob A Quaytman, Yuri E Nikiforov, Marina N Nikiforova, and Elena Morariu

Volume 29: Issue 9,
Pages:: 513–520 (8 total)

Congenital hypothyroidism and thyroid cancer

Authors: Gustavo Penna, Ileana G S Rubio, Ester Saraiva Brust, Juliana Cazarin, Fabio Hecht, Nina Ramalho Alkmim, Kamilla M A Brandão Rajão, and Helton Estrela Ramos

Volume 28: Issue 9,
Pages:: R217–R230

Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis

Authors: T P Links, K M van Tol, P L Jager, J Th M Plukker, D A Piers, H M Boezen, R P F Dullaart, E G E de Vries, and W J Sluiter

Volume 12: Issue 2,
Pages:: 273–280 (8 total)

New therapeutic opportunities for women with low-grade serous ovarian cancer

Authors: Tania Moujaber, Rosemary L Balleine, Bo Gao, Ida Madsen, Paul R Harnett, and Anna DeFazio

Volume 29: Issue 1,
Pages:: R1–R16

Phytoestrogens and breast cancer –promoters or protectors?

Authors: Suman Rice and Saffron A Whitehead

Volume 13: Issue 4,
Pages:: 995–1015 (21 total)

80 Years of Androgen Deprivation as a Treatment for Prostate Cancer special issue advert

Tweets by @EndoCancer

Read the top 10 most downloaded articles published in 2020

Androgen hazards with COVID-19

Authors: Nima Sharifi and Charles J Ryan
Volume 27: Issue 6, Pages: E1–E3

The epigenetic and transcriptional landscape of neuroendocrine prostate cancer

Authors: Alastair Davies, Amina Zoubeidi, and Luke A Selth
Volume 27: Issue 2, Pages: R35–R50

The treatment of renal hyperparathyroidism

Authors: Martin Almquist, Elin Isaksson, and Naomi Clyne
Volume 27: Issue 1, Pages: R21–R34

Neuroendocrine neoplasm update: toward universal nomenclature

Authors: Guido Rindi and Frediano Inzani
Volume 27: Issue 6, Pages: R211–R218

Mebendazole inhibits tumor growth and prevents lung metastasis in models of advanced thyroid cancer

Authors: Tara Williamson et al.
Volume 27: Issue 3, Pages: 123–136

Read the top 10 most cited articles of 2020, published in 2019

Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study

Authors: Esben Andreas Carlsen et al.
Volume 26: Issue 2, Pages: E1–E3

French Endocrine Society Guidance on endocrine side effects of immunotherapy

Authors: F Castinetti et al.
Volume 26: Issue 2, Pages: G1–G18

Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer

Authors: Neil Portman et al.
Volume 26: Issue 1, Pages: R15–R30

Novel circular RNA circNF1 acts as a molecular sponge, promoting gastric cancer by absorbing miR-16

Authors: Zhe Wang et al.
Volume 26: Issue 3, Pages: 265–277

Genotype–phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis

Authors: Joakim Crona et al.
Volume 26: Issue 5, Pages: 539–550